FDA approves 1st drug for moderate & severe eczema cases

TRENTON, N.J. - U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema.The Food and Drug Administration on Tuesday approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and legs.